ACAM2000 information

ACAM2000 is a smallpox vaccine manufactured by Sanofi Pasteur Biologics Co. It provides protection against smallpox for people determined to be at high...

Vero cells to develop ACAM2000, which entered mass production at Baxter. The United States ordered over 200 million doses of ACAM2000 in 1999–2001 for its...

with ACAM2000 is 5.7 per 1,000 of primary vaccinees. On September 1, 2007, the U.S. Food and Drug Administration (FDA) licensed a new vaccine ACAM2000 against...

a smallpox vaccination in comparison with a COVID-19 vaccination. The ACAM2000 smallpox vaccine has been known to cause myopericarditis in some people...

be administered intravenously, and may cause serious kidney toxicity. ACAM2000 is a smallpox vaccine developed by Acambis. It was approved for use in...

casein, dextrose, galactose, lactose, sucrose, yeast extract Vaccinia (ACAM2000) Glycerin, human serum albumin, mannitol, neomycin, phenol, polymyxin B...

Varilrix, Varivax, Zostavax Smallpox vaccine Variola virus DNA Smallpox ACAM2000, Dryvax, Imvanex, Jynneos Yellow fever vaccine Yellow fever virus RNA Yellow...

Emergent in arbitration proceedings. In 2017, the company purchased the ACAM2000 (smallpox vaccinia) Vaccine, the only FDA-approved (2007)vaccine for active...

Archived from the original on 26 November 2020. Retrieved 27 December 2020. "ACAM2000 Product Insert". US Food & Drug Administration. Emergent Product Development...

resulting from continued vaccinia virus replication after vaccination using ACAM2000 or APSV. VIGIV is not commercially available but can be made available...